|
|
???tair.name??? >
???browser.page.title.author???
|
"lin yun chu"???jsp.browse.items-by-author.description???
Showing items 1-17 of 17 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-04-26T08:21:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien, Feng-Ming; Liu, Jia-Hau; WEN-CHIEN CHOU; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; Lin, Yun-Chu; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-03-04T03:52:50Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; SHANG-JU WU; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-01-12T08:28:38Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Chieh-Lung Cheng; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-01-10T09:11:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2021-11-24T07:22:42Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; CHIEN-CHIN LIN; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2021-11-21T23:19:44Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu Wen; Tsai, Xavier Cheng Hong; HSIN-AN HOU; Tien, Feng Ming; Liu, Jia Hau; WEN-CHIEN CHOU; BOR-SHENG KO; YU-WEN CHEN; CHIEN-CHIN LIN; Cheng, Chieh Lung; Lo, Min Yen; Lin, Yun Chu; Lu, Li Chun; SHANG-JU WU; SUNG-HSIN KUO; Hong, Ruey Long; TAI-CHUNG HUANG; MING YAO |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou H.-A.; LIN YUN-CHU; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:29Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; LIN YUN-CHU; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2020-12-09T00:46:09Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Lin, Chien-Chin; Tien, Feng-Ming; Chen, Yu-Wen; Lin, Hsing-Yu; MING YAO; Lin, Yun-Chu; Lin, Chien-Ting; Chieh-Lung Cheng; Tang, Jih-Luh; Chou, Wen-Chien; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2020-10-28T02:42:55Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; JIH-LUH TANG; Lee, Sze-Hwei; CHENG-HONG TSAI; Wu, Shan-Ju; HSIN-AN HOU; TAI-CHUNG HUANG; YUAN-YEH KUO; MING YAO; Chang, Koping; CHUNG-WU LIN; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien; HWEI-FANG TIEN; CHIEN-CHIN LIN |
| 臺大學術典藏 |
2020-10-12 |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; Tien, Hwei-Fang; Tang, Jih-Luh; Lin, Chien-Chin; Lee, Sze-Hwei; Tsai, Cheng-Hong; Wu, Shan-Ju; Hou, Hsin-An; Huang, Tai-Chung; Kuo, Yuan-Yeh; MING YAO; Chang, Koping; Lin, Chung-Wu; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien |
| 臺大學術典藏 |
2018-09-10T15:26:52Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou, H.-A. and Lin, Y.-C. and Kuo, Y.-Y. and Chou, W.-C. and Lin, C.-C. and Liu, C.-Y. and Chen, C.-Y. and Lin, L.-I. and Tseng, M.-H. and Huang, C.-F. and Chiang, Y.-C. and Liu, M.-C. and Liu, C.-W. and Tang, J.-L. and Yao, M. and Huang, S.-Y. and Ko, B.-S. and Hsu, S.-C. and Wu, S.-J. and Tsay, W. and Chen, Y.-C. and Tien, H.-F.; Liu, Ming-Chih; Liu, Chia-Wen; Tang, Jih-Luh; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang; ???y?g; Chiang, Ying-Chieh; Huang, Chi-Fei; SHANG-YI HUANG; Huang, Chi-Fei; MING YAO; Tseng, Mei-Hsuan; Tseng, Mei-Hsuan; Lin, Liang-In; Lin, Liang-In; CHIEN-CHIN LIN; LIANG-IN LIN; Chen, Chien-Yuan; Liu, Chieh-Yu; HWEI-FANG TIEN; HSIN-AN HOU; Lin, Yun-Chu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU; Chou, Wen-Chien; YUAN-YEH KUO; Lin, Chien-Chin; BOR-SHENG KO; JIH-LUH TANG; Liu, Chieh-Yu; 林建嶔;林吉崇;蔡偉;林亮音;姚明;陳建源;陳耀昌;柯博升;徐思淳;田蕙芬;劉敏枝;陳宜君;郭遠燁;黃聖懿;吳尚儒;唐季祿;周文堅;侯信安; Hou, Hsin-An; Hou, Hsin-An; Hou, Hsin-An;Lin, Yun-Chu;Kuo, Yuan-Yeh;Chou, Wen-Chien;Lin, Chien-Chin;Liu, Chieh-Yu;Chen, Chien-Yuan;Lin, Liang-In;Tseng, Mei-Hsuan;Huang, Chi-Fei;Chiang, Ying-Chieh;Liu, Ming-Chih;Liu, Chia-Wen;Tang, Jih-Luh;Yao, Ming;Huang, Shang-Yi;Ko, Bor-Sheng;Hsu, Szu-Chun;Wu, Shang-Ju;Tsay, Woei;Chen, Yao-Chang;Tien, Hwei-Fang; Hou, Hsin-An;Lin, Yun-Chu;Kuo, Yuan-Yeh;Chou, Wen-Chien;Lin, Chien-Chin;Liu, Chieh-Yu;Chen, Chien-Yuan;Lin, Liang-In;Tseng, Mei-Hsuan;Huang, Chi-Fei;Chiang, Ying-Chieh;Liu, Ming-Chih;Liu, Chia-Wen;Tang, Jih-Luh;Yao, Ming;Huang, Shang-Yi;Ko, Bor-Sheng;Hsu, Szu-Chun;Wu, Shang-Ju;Tsay, Woei;Chen, Yao-Chang;Tien, Hwei-Fang |
| 臺大學術典藏 |
2018-09-10T14:49:38Z |
Long-term outcome of patients with acute cholecystitis receiving antibiotic treatment: A retrospective cohort study
|
Wang, C.-H. and Chou, H.-C. and Liu, K.-L. and Lien, W.-C. and Wang, H.-P. and Wu, Y.-M.; Wang, Chih-Hung;Chou, Hao-Chang;Liu, Kao-Lang;Lien, Wan-Ching;Wang, Hsiu-Po;Wu, Yao-Ming; 連琬菁;王秀伯;王志宏;劉高郎;吳耀銘; CHIH-HUNG WANG; Hou, Hsin-An; Wang, Chih-Hung; KAO-LANG LIU; Lin, Yun-Chu; Chou, Hao-Chang; WAN-CHING LIEN; Liu, Kao-Lang; Kuo, Yuan-Yeh; Chou, Wen-Chien; Lien, Wan-Ching; YAO-MING WU; Wang, Hsiu-Po; Lin, Chien-Chin; Wu, Yao-Ming; Liu, Chieh-Yu; Chen, Chien-Yuan; Lin, Liang-In; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Tang, Jih-Luh; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang; ?L??k; ?L?N?R; ????; ?L?G??; ????; ?????; ?????; ?_???; ?}??E; ?????; ?B??K; ???y?g; ?????M; ???t?t; ?d?|??; ??u?S; ?P???; ?J?H?w |
| 國立臺北護理健康大學 |
2015-02 |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou, Hsin An;Lin, Yun Chu;Kuo, Yuan Yeh;Chou, Wen Chien;Lin, Chien Chin;Liu, Chieh Yu;Chen, Chien Yuan;Lin, Liang In;Tseng, Mei Hsuan;Huang, Chi Fei;Chiang, Ying Chieh;Liu, Ming Chih;Liu, Chia Wen;Tang, Jih Luh;Yao, Ming;Huang, Shang Yi;Ko, Bor Sheng;Hsu, Szu Chun;Wu, Shang Ju;Tsay, Woei;Chen, Yao Chang;Tien, Hwei Fang |
| 國立臺灣大學 |
2015 |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou, Hsin-An; Lin, Yun-Chu; Kuo, Yuan-Yeh; Chou, Wen-Chien; Lin, Chien-Chin; Liu, Chieh-Yu; Chen, Chien-Yuan; Lin, Liang-In; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Tang, Jih-Luh; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang; 林建嶔; 林吉崇; 蔡偉; 林亮音; 姚明; 陳建源; 陳耀昌; 柯博升; 徐思淳; 田蕙芬; 劉敏枝; 陳宜君; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
2010 |
營建業國際化過程之動態折衷模型
|
林芸竹; Lin, Yun-Chu |
Showing items 1-17 of 17 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
